Is Cooper Companies Stock Underperforming the Dow?

Company Overview - The Cooper Companies, Inc. (COO) is based in California and specializes in developing, manufacturing, and marketing products for contact lens wearers, with a market capitalization of $13.9 billion [1] - COO operates in two segments: CooperVision, which offers various types of contact lenses, and CooperSurgical, which provides fertility products, medical devices, contraception, and cryostorage services for women [1] Market Performance - COO stock has decreased by 20.9% from its 52-week high of $89.83 reached on December 5, 2025, and has declined 12.3% over the past three months, underperforming the Dow Jones Industrials Average, which fell by 2.4% during the same period [3][6] - Over the past 52 weeks, COO has seen a decline of 12.5%, while the Dow Jones Industrials Average has gained 13.2% [6] Recent Earnings Report - On March 5, COO reported mixed Q1 2026 earnings, with revenue increasing nearly 6% year-over-year to $1 billion, aligning with market estimates [7] - The adjusted EPS for the quarter rose by 20% from the previous year to $1.10, surpassing Wall Street expectations [7] - Despite the positive earnings, investor confidence waned due to weak organic revenue growth and slower business performance in the Asia Pacific region, leading to a 4.6% drop in stock price in the following trading session [7] Competitive Positioning - Compared to its peer Align Technology, Inc. (ALGN), COO has underperformed, with ALGN stock growing by 2% over the past year [8] - Sentiment towards COO remains moderately optimistic, with a consensus rating of "Moderate Buy" among 18 analysts and a mean price target of $90.81, indicating a potential upside of 27.8% from current levels [8]